Elevated IL-6 and IL-22 in Early Pregnancy Are Associated with Worse Disease Course in Women with Inflammatory Bowel Disease

Int J Mol Sci. 2022 Sep 7;23(18):10281. doi: 10.3390/ijms231810281.

Abstract

Inflammatory bowel diseases (IBD), including Ulcerative Colitis (UC) and Crohn’s disease (CD), are inflammatory conditions of the intestinal tract that affect women in their reproductive years. Pregnancy affects Th1- and Th2-cytokines, but how these changes occur during pregnancy in IBD is unclear. We performed a longitudinal profiling of serum cytokines in a cohort of 11 healthy pregnant women and 76 pregnant women with IBD from the first trimester of pregnancy to the first 12 months post-partum. Participants were monitored for biochemical disease activity (C-reactive protein [CRP] and fecal calprotectin [FCP]) and clinical activities. Maternal cytokines were measured using ELISA. We identified changes in Th1 and Th17 cytokines throughout pregnancy in healthy pregnant women. During pregnancy, maternal serum cytokine expressions were influenced by IBD, disease activity, and medications. Active UC was associated with an elevation in IL-21, whereas active CD was associated with elevated IFN-γ, IL-6, and IL-21. Interestingly, T1 serum cytokine levels of IL-22 (>0.624 pg/mL) and IL-6 (>0.648 pg/mL) were associated with worse IBD disease activity throughout pregnancy in women with UC and CD, respectively. This shows serum cytokines in pregnancy differ by IBD, disease activity, and medications. We show for the first time that T1 IL-22 and IL-6 correlate with IBD disease course throughout pregnancy.

Keywords: CD; IL-22; IL-6; UC; cytokines; pregnancy.

MeSH terms

  • C-Reactive Protein / metabolism
  • Colitis, Ulcerative*
  • Crohn Disease*
  • Cytokines / metabolism
  • Disease Progression
  • Female
  • Humans
  • Inflammatory Bowel Diseases*
  • Interleukin-22
  • Interleukin-6 / metabolism
  • Interleukins
  • Leukocyte L1 Antigen Complex
  • Pregnancy

Substances

  • Cytokines
  • Interleukin-6
  • Interleukins
  • Leukocyte L1 Antigen Complex
  • C-Reactive Protein

Grants and funding

The project is supported by local research support from CEGIIR, the University of Alberta Department of Medicine and Department of Gastroenterology, and the Mount Sinai Hospital Department of Medicine.